Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 6

See more details

Referenced in 2 patents
Referenced in 2 Wikipedia pages
52 readers on Mendeley
  • Article usage
  • Citations to this article (291)

Advertisement

Research Article Free access | 10.1172/JCI114812

Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.

L A Diaz, H Ratrie 3rd, W S Saunders, S Futamura, H L Squiquera, G J Anhalt, and G J Giudice

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Diaz, L. in: PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Ratrie, H. in: PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Saunders, W. in: PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Futamura, S. in: PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Squiquera, H. in: PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Anhalt, G. in: PubMed | Google Scholar

Department of Dermatology, Medical College of Wisconsin, Milwaukee 53226.

Find articles by Giudice, G. in: PubMed | Google Scholar

Published October 1, 1990 - More info

Published in Volume 86, Issue 4 on October 1, 1990
J Clin Invest. 1990;86(4):1088–1094. https://doi.org/10.1172/JCI114812.
© 1990 The American Society for Clinical Investigation
Published October 1, 1990 - Version history
View PDF
Abstract

Autoantibodies present in the sera of patients with bullous pemphigoid (BP) bind to the basement membrane zone of normal human skin and commonly recognize two epidermal proteins, the BP240 and BP180 antigens. Two BP antigen cDNA clones from a lambda gt11 human keratinocyte library have been identified on the basis of reactivity with a BP serum. The fusion protein (FP) produced by one clone immunoadsorbed autoantibodies, which specifically recognized the BP180 by antigen, showing no cross-reactivity with BP240 by immunoblot analysis. The FP produced by the second clone immunoadsorbed autoantibodies which specifically reacted with the BP240 epidermal antigen. Northern blot analysis demonstrated that the BP180 and BP240 antigens are encoded by distinct RNA transcripts with lengths of 6.0 and 8.5 kb, respectively. Immunoblot analysis of the BP180 lysogen extract identified a 135-kD FP which was recognized by 7 of 16 BP sera and 7 of 8 herpes gestationis sera. A rabbit antiserum prepared against the lysogenic BP180 FP specifically recognized the BP180 antigen from human epidermal extracts by immunoblotting, labeled the BMZ by indirect immunofluorescence, and bound to human epidermal hemidesmosomes by immuno-electron microscopy. These results indicate that the BP180 antigen recognized by BP and herpes gestationis autoantibodies is a unique hemidesmosomal polypeptide, distinguishable from the BP240 antigen.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1088
page 1088
icon of scanned page 1089
page 1089
icon of scanned page 1090
page 1090
icon of scanned page 1091
page 1091
icon of scanned page 1092
page 1092
icon of scanned page 1093
page 1093
icon of scanned page 1094
page 1094
Version history
  • Version 1 (October 1, 1990): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 6
  • Article usage
  • Citations to this article (291)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
Referenced in 2 Wikipedia pages
52 readers on Mendeley
See more details